Search Results 81-90 of 16469 for Phenothiazines

  1. Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE) - Mayo Clinic

    The purpose of this study is to determine whether ornithine phenylacetate can speed recovery from an acute hepatic encephalopathy episode requiring ...

  2. Convergence Insufficiency Treatment Study (CITS) - Mayo Clinic

    ... phenothiazines (e.g., Compazine, Mellaril, Thorazine), tricyclic antidepressants (e.g., Elavil, Nortriptyline, Tofranil); Near point of accommodation >20 cm ...

  3. Immunosuppressants · Cyclosporine (Gengraf, Neoral, Sandimmune). · Tacrolimus (Astagraf XL, Prograf, Envarsus XR).

  4. Fezolinetant (oral route) - Side effects & dosage - Mayo Clinic

    Description. Fezolinetant is used to reduce moderate to severe symptoms of menopause, including feelings of warmth in the face, neck, and chest, ...

  5. A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM - Mayo Clinic

    thiazide diuretics, sulfonylureas, phenothiazines, tetracyclines, sulfonamides, quinolones, hypericin extracts, topical preparations containing ALA) within ...

  6. Consumer health Medications - Mayo Clinic

    Meditation. Yoga. Massage. Acupuncture. Use of supplements, such as vitamins, herbs and minerals. Music therapy. Integrative medicine aims to fit each person's ...

  7. Antidepressants such as MAOIs ease depression by controlling chemical messengers called neurotransmitters that carry messages between brain cells and affect ...

  8. The Food and Drug Administration (FDA) approved these atypical antidepressants to treat depression: Bupropion (Wellbutrin SR, Wellbutrin XL, others) ...

  9. Consider other strategies to prevent teen drug abuse: Know your teen's activities. Pay attention to your teen's whereabouts. Find out what adult-supervised ...

  10. Pharmacogenomics (PGx) results and clinical data for assessing current and future therapeutic relevance.

    The goal of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a group of patients in order ...